Doç. Dr. SEÇİL DEMİRKOL CANLI

Yayın Ağı

Makaleler 21

1. AKR1B1 Expression in the Colorectal Tumor Microenvironment Contributes Towards Its Prognostic Significance

DEMİRKOL CANLI S., GÜNER GEBEŞ G., Isik A., Sosic-Jurjevi B., Rom A. D., SEZA E. G., et al.

CANCER MEDICINE , cilt.14, sa.10, 2025 (SCI-Expanded) Sürdürülebilir Kalkınma

2. Glutamine withdrawal leads to the preferential activation of lipid metabolism in metastatic colorectal cancer

Taskiran A. E. G., Karaoglu D. A., EYLEM C. C., Ermis C., Guederer I., NEMUTLU E., et al.

TRANSLATIONAL ONCOLOGY , cilt.48, 2024 (SCI-Expanded)

3. Breast Cancer Plasticity after Chemotherapy Highlights the Need for Re-Evaluation of Subtyping in Residual Cancer and Metastatic Tissues

Demirkol Canlı S.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES , cilt.25, sa.11, ss.6054-6065, 2024 (SCI-Expanded)

4. Enterotoxins A and B produced by Staphylococcus aureus increase cell proliferation, invasion and cytarabine resistance in acute myeloid leukemia cell lines.

TÜRK S., Yanpar H., Baesmat A. S., Canli S., ÇINAR O. E., MALKAN Ü. Y., et al.

Heliyon , cilt.9, sa.9, 2023 (SCI-Expanded)

5. Claudin 18.2 Expression in Gastric Adenocarcinomas in a Large Turkish Cohort

Işık A., GÜNER G., Zeyneloğlu C., DEMİRKOL CANLI S., TAŞTAN H., AKYOL A.

Abant Tıp Dergisi , cilt.12, sa.2, ss.122-130, 2023 (Hakemli Dergi)

6. A Novel Gene List Identifies Tumors with a Stromal-Mesenchymal Phenotype and Worse Prognosis in Gastric Cancer

Demirkol Canlı S., Üner M., Kucukkaraduman B., Karaoglu D. A., Isik A., Turhan N., et al.

Cancers , cilt.15, sa.11, 2023 (SCI-Expanded)

7. A positive feedback loop driven by fibronectin and IL-1β sustains the inflammatory microenvironment in breast cancer

TUNALI G., Yanik H., ÖZTÜRK S. C., DEMİRKOL CANLI S., Efthymiou G., Yilmaz K. B., et al.

Breast cancer research : BCR , cilt.25, sa.1, ss.27, 2023 (SCI-Expanded)

8. Transcriptomic Analysis of Hepatitis B Infected Liver for Prediction of Hepatocellular Carcinoma

Karaoglu D. A., ÜNER M., ŞİMŞEK C., GÜRE A. O., DEMİRKOL CANLI S.

Biology , cilt.12, sa.2, 2023 (SCI-Expanded)

9. CSRP1 expression is associated with a mesenchymal, stroma-rich tumor profile and poor prognosis in colon cancer

DEMİRKOL CANLI S.

Turkish Journal of Medical Sciences , cilt.53, sa.6, ss.1678-1689, 2023 (SCI-Expanded)

10. Prognostic value of midkine, syndecan-1, hyaluronan synthase-2, sestrin-1, laminin subunit alpha-4 and fibulin-3 for malignant pleural mesothelioma

Akgun H., METİNTAŞ S., AK G., Canlı S., Isbilen M., Gure A. O., et al.

Archives of Medical Science , cilt.19, sa.2, ss.355-364, 2023 (SCI-Expanded)

11. Gastric Carcinoma with Lymphoid Stroma: A Combination of Mismatch Repair Deficient Medullary Type and Epstein–Barr Virus-associated Gastric Carcinomas

Üner M., Isık A., Oztop S., Karabulut E., Demirkol Canlı S., Akyol A.

International Journal of Surgical Pathology , cilt.30, sa.6, ss.623-633, 2022 (SCI-Expanded)

12. Kolorektal kanserde kanser ilişkili fibroblast temelli altgruplarda prognoztik belirteçlerin değerlendirilmesi

Demirkol Canlı S.

Acta Medica , cilt.53, sa.2, ss.133-143, 2022 (Hakemli Dergi)

13. Quality assurance: Evaluation and comparison of methods for electron microscopic measurement of GBM width and the effect of in-lab calibration in diagnostic renal pathology.

Uner M., Demirkol Canlı S., Arend L. J.

Microscopy research and technique , cilt.85, sa.1, ss.290-295, 2022 (SCI-Expanded)

14. Dna methylation of pi3k/akt pathway-related genes predicts outcome in patients with pancreatic cancer: A comprehensive bioinformatics-based study

Faleiro I., Roberto V. P., Canli S., Fraunhoffer N. A., Iovanna J., Gure A. O., et al.

Cancers , cilt.13, sa.24, 2021 (SCI-Expanded)

15. Epithelial-to-Mesenchymal Transition Is Not a Major Modulating Factor in the Cytotoxic Response to Natural Products in Cancer Cell Lines.

Kucukkaraduman B., Cicek E. G., Akbar M. W., Demirkol Canli S., Vural B., Gure A. O.

Molecules (Basel, Switzerland) , cilt.26, sa.19, 2021 (SCI-Expanded)

16. Renin angiotensin system genes are biomarkers for personalized treatment of acute myeloid leukemia with Doxorubicin as well as etoposide

Turk S., Turk C., Akbar M., Kucukkaraduman B., Isbilen M., Demirkol C., et al.

PLOS ONE , cilt.15, sa.11, 2020 (SCI-Expanded)

17. Evaluation of an aldo-keto reductase gene signature with prognostic significance in colon cancer via activation of epithelial to mesenchymal transition and the p70S6K pathway.

Demirkol C., Seza E., Sheraj I., Gömçeli I., Turhan N., Carberry S., et al.

Carcinogenesis , cilt.41, ss.1219-1228, 2020 (SCI-Expanded)

18. A novel 20-gene prognostic score in pancreatic adenocarcinoma

Canli S., Dedeoglu E., Akbar M. W., Kucukkaraduman B., Isbilen M., Erdogan O. S., et al.

PLOS ONE , cilt.15, sa.4, 2020 (SCI-Expanded)

19. A Sternness and EMT Based Gene Expression Signature Identifies Phenotypic Plasticity and is A Predictive but Not Prognostic Biomarker for Breast Cancer

Akbar M. W., Isbilen M., Belder N., Canli S., Kucukkaraduman B., Turk C., et al.

JOURNAL OF CANCER , cilt.11, sa.4, ss.949-961, 2020 (SCI-Expanded)

20. Opposing roles of the aldo-keto reductases AKR1B1 and AKR1B10 in colorectal cancer.

TASKOPARAN B., SEZA E., Demirkol S., TUNCER S., STEFEK M., GURE A., et al.

Cellular oncology (Dordrecht) , cilt.40, ss.563-578, 2017 (SCI-Expanded)

21. A Combined ULBP2 and SEMA5A Expression Signature as a Prognostic and Predictive Biomarker for Colon Cancer.

Demirkol S., GOMCELI I., ISBILEN M., DAYANC B., TEZ M., BOSTANCI E. Ö., et al.

Journal of Cancer , cilt.8, ss.1113-1122, 2017 (SCI-Expanded)

Kitaplar 1

1. Uygulamaya Yönelik Genetik Bilimci Gözüyle Kanserde Gelecek Öngörüleri

Demirkol Canlı S., Güre A. O., Akçay A. G., Akbar M. W.

Kanser Moleküler Biylojisi, Baran Y, Editör, Hipokrat Yayınevi, Ankara, ss.519-529, 2018

Metrikler

Yayın

Yayın (WoS)

Yayın (Scopus)

Atıf (WoS)

106

H-İndeks (WoS)

Atıf (Scopus)

110

H-İndeks (Scopus)

Proje

Fikri Mülkiyet

Açık Erişim

BM Sürdürülebilir Kalkınma Amaçları

Yayınlar & Eserler